This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:physicians:emergency [09.16.2017] – [Notice for emergency medical personnel] sallieq | home:physicians:emergency [11.21.2018] – [Notice for emergency medical personnel] sallieq | ||
---|---|---|---|
Line 36: | Line 36: | ||
- | These antibiotics | + | The listed |
* azithromycin (note especially cardiovascular sequelae) | * azithromycin (note especially cardiovascular sequelae) | ||
* clindamycin | * clindamycin | ||
Line 53: | Line 53: | ||
Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. | Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. | ||
**A specific antidote for rivaroxaban is not available.** | **A specific antidote for rivaroxaban is not available.** | ||
+ | |||
+ | Colistin (Colimycin, Colisticin, Colistin Sulfate, Coly-Mycin, Polymyxin ESulfate, Totazina) is not suitable for treating MP patients. | ||
Adverse reactions may occur if epinephrine or norepinephrine | Adverse reactions may occur if epinephrine or norepinephrine |